Nature: Ebola funding surge hides falling investment in other neglected diseases
“Global funding for research on neglected diseases — which include tuberculosis, HIV/AIDS, and malaria — is at its lowest level since 2007, according to the annual G-FINDER investment report by Policy Cures Research, a health policy analysis firm in Sydney, Australia. But that total — just over US$3 billion for 2015, the latest year for which figures are available — does not include a rapid burst of funding for research into Ebola to tackle the outbreak in West Africa. Investments in Ebola and other African viral hemorrhagic fevers shot up to $631 million in 2015 — more than was spent on any other neglected disease except HIV/AIDS…” (Ross et al., 2/16).